Free Trial

BioSig Technologies (BSGM) Stock Price, News & Analysis

+0.05 (+12.50%)
(As of 06/14/2024 ET)
Today's Range
50-Day Range
52-Week Range
191,948 shs
Average Volume
449,832 shs
Market Capitalization
$6.38 million
P/E Ratio
Dividend Yield
Price Target
BSGM stock logo

About BioSig Technologies Stock (NASDAQ:BSGM)

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

BSGM Stock Price History

BSGM Stock News Headlines

BioSig Technologies Inc.
Biosig Technologies Inc (BSGM)
BioSig Announces Reduction of its Workforce
BioSig Announces Reduction of its Workforce
See More Headlines
Receive BSGM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Electromedical equipment
Current Symbol
Year Founded


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
Book Value
($0.33) per share


Free Float
Market Cap
$6.38 million
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Frederick D. Hrkac (Age 58)
    President, Principal Executive Officer, Executive VP & Director
  • Mr. Anthony Amato (Age 56)
    CEO & Director
  • Dr. Budimir S. Drakulic Ph.D. (Age 74)
    Chief Scientist
    Comp: $169.64k
  • Mr. Andrew Gornell Ballou
    Vice President of Investor Relations

BSGM Stock Analysis - Frequently Asked Questions

How have BSGM shares performed in 2024?

BioSig Technologies' stock was trading at $4.75 at the start of the year. Since then, BSGM stock has decreased by 90.5% and is now trading at $0.4499.
View the best growth stocks for 2024 here

Are investors shorting BioSig Technologies?

BioSig Technologies saw a decrease in short interest in May. As of May 31st, there was short interest totaling 223,800 shares, a decrease of 51.5% from the May 15th total of 461,700 shares. Based on an average daily trading volume, of 985,800 shares, the days-to-cover ratio is presently 0.2 days. Approximately 2.0% of the company's shares are short sold.
View BioSig Technologies' Short Interest

When is BioSig Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024.
View our BSGM earnings forecast

How were BioSig Technologies' earnings last quarter?

BioSig Technologies, Inc. (NASDAQ:BSGM) released its quarterly earnings data on Monday, May, 20th. The company reported ($0.36) EPS for the quarter. The business earned $0.01 million during the quarter.

When did BioSig Technologies' stock split?

BioSig Technologies's stock reverse split on the morning of Friday, February 2nd 2024. The 1-10 reverse split was announced on Friday, February 2nd 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 2nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of BioSig Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Roku (ROKU), Advanced Micro Devices (AMD), Amarin (AMRN), Dynavax Technologies (DVAX), Vaxart (VXRT), Telefonaktiebolaget LM Ericsson (publ) (ERIC) and Micron Technology (MU).

Who are BioSig Technologies' major shareholders?

BioSig Technologies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include PFG Investments LLC (0.95%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Gray Fleming, John Sieckhaus, Kenneth L Londoner, Kenneth L Londoner, Patrick Joseph Gallagher and Steve Chaussy.
View institutional ownership trends

How do I buy shares of BioSig Technologies?

Shares of BSGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BSGM) was last updated on 6/16/2024 by Staff

From Our Partners